Evidence show that both the pro-inflammatory mediators and vascular endothelial growth factor (VEGF) are the leading causes of macular edema [7], thus ME can be controlled with anti-VEGF or anti-inflammatory agents. The gene discussed is VEGFA; the disease is macular retinal edema.